MULTI BAGGER ALERTS

[KeepItRealistic]

$GRCK @ .0117 close

Reversal in progress

Just acquired Eqova.com, a Clinical-grade CBD product company exclusive for doctors from doctors.

CBD Company - CEO is at MJBIZCON this week in vegas to drum up sales & relationships.

Check out CEO recent video

Extremely low market cap of 1.5 million.

Latest News
http://m.marketwired.com/press-release/grey-cloak-tech-inc-to-introduce-cannabio-salve-at-mjbizcon-in-las-vegas-otcqb-grck-2240010.htm

All PR’s
http://www.otcmarkets.com/stock/GRCK/news

Free L2 link as its an OTCQB ticker
http://www.otcmarkets.com/stock/GRCK/quote

Share Structure , very tiny market cap & float for a CDB company
http://www.otcmarkets.com/stock/GRCK/profile

GRCK Security Details
Share Structure
Market Value1 $1,496,121 a/o Nov 13, 2017

Authorized Shares 500,000,000 a/o Nov 07, 2017

Outstanding Shares 141,143,444 a/o Nov 07, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 133,823,444 a/o Nov 07, 2017
0.001

37% insider ownership !
https://www.otcmarkets.com/financialReportViewer?symbol=GRCK&id=181626

Large insider ownership usually means they will want a substantial increase in the pps.

Article on acquisition (Uncompensated)
http://psinvestor.com/grey-cloak-delivers-eqova-acquision-with-solid-structure-sets-stage-for-rebound/

Another article
https://www.networknewswire.com/strategic-acquisition-enables-grey-cloak-tech-inc-s-grck-development-two-industries/

Recently Uplisted to OTCQB, Audited

Cancelled RS replaced with increased AS

Form 14PRE: https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12360234.

The highlights:

- They are planning to vote on Dec 29 to increase the AS to 1 billion shares

- Reason for AS increase - "As a general matter, the Board of Directors does not believe the currently available number of unissued shares of Common Stock is an adequate number of shares to assure that there will be sufficient shares available for issuance in connection with possible future acquisitions, equity and equity-based financings, possible future awards under employee benefit plans, stock dividends, stock splits, and other corporate purposes."
- Insiders and 5% stakeholders own around 168 million shares of common stock

Company is targeting a niche market with products ready to sell and an experienced management team who own 90 million shares (skin in the game). See form 4 & 3’s

Warrants at .25

Strong following on Twitter (74,000)

$GRCK Grey Cloak Tech Completes Acquisition of Eqova Life Sciences https://t.co/PnOEuwjDOO via @Marketwired #investors #CBD #microcaps pic.twitter.com/qqefZxsv1s

— GreyCloakTech (@GreyCloakTech) October 25, 2017

Eqova are Clinical-grade CBD products.

“Eqova's products are created using full spectrum hemp oil and other ingredients to achieve standardized dosing. These formulations combine the scientifically validated, powerful benefits of cannabinoids in standardized products, which are then distributed to patients under the care of licensed health practitioners. All Eqova products are carefully researched and go through rigorous third-party testing before and after marketing, providing clinical-grade products made in cGMP Compliant Labs located in the United States.

Hypothetical future pps potential based on sector sentiment.

conservatively .25+ within first quarter of 2018 based on other tickers in the same sector trading today.

Much higher is very plausible later in 2018

Reminder of some current facts
- float is less than 150 million
- insider ownership is 37%
- Market cap is only 1.5 million
- CBD products are ready to sell

At .10 our market cap would be 15 mil

At .20 our market cap would be 30 mil

At .50 our market cap would be 75 mil

The sector: MJNA has a 300 plus million market cap and if you look at their description, they do CBD products.

Clearly extremely under valued at 1.5 million market.